Erucic acid aggravates cardiac fibrosis after myocardial infarction by CD36-mediated metabolic reprogramming with impaired mitochondrial aerobic oxidation
Cellular Signalling · 2026-10 · 146 · 112636
DOI: 10.1016/j.cellsig.2026.112636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-10. Verfasst von Meng Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Laboratory of Neuroscience and Tissue Engineering, Basic Medical College of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: CD36 Antigens, Myocardial Infarction, Erucic Acids, Mitochondria. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Municipal Education Commission.
Abstract (Originalsprache)
BACKGROUND: Post-myocardial infarction (MI) cardiac fibrosis is a key driver of heart failure, with dysregulated cardiac metabolism playing a central role. The specific impact of circulating fatty acid metabolites on mitochondrial function and fibrotic remodeling remains unclear. Erucic acid, a very-long-chain fatty acid found in certain edible oils, has a historical association with cardiac lipidosis, yet its causal role and mechanism in post-MI fibrosis are unknown. METHODS: We employed an integrative, two-stage strategy. First, a hypothesis-free two-sample Mendelian Randomization (MR) analysis was performed using genome-wide association study (GWAS) data for 1400 serum metabolites and MI (FinnGen consortium) to identify causal risk metabolites. Second, the top-ranked metabolite, erucic acid, was functionally validated in vivo and in vitro. A murine MI model with graded dietary erucic acid supplementation was used to assess cardiac function, fibrosis, oxidative stress, mitochondrial ultrastructure, and energy metabolism. RNA-seq was performed to elucidate global pathway alterations. Complementary in vitro studies in TGF-β-stimulated HL-1 cardiomyocytes and in vivo AAV9-mediated cardiomyocyte-specific CD36 overexpression rescue experiments were conducted to dissect the molecular mechanism involving the CD36 lipid metabolism axis. RESULTS: MR analysis identified erucic acid as a putative causal risk metabolite for MI. In mice, erucic acid levels increased post-MI, and dietary supplementation dose-dependently exacerbated cardiac dysfunction, fibrosis, oxidative stress, and mitochondrial damage. High-dose erucic acid induced a severe metabolic shift, characterized by suppressed mitochondrial oxidative phosphorylation and enhanced glycolysis. In vitro, erucic acid suppressed the CD36 pathway and downstream lipid-handling enzymes, leading to aggravated lipid peroxidation (increased 4-HNE/rH2X, decreased SOD2). Crucially, in vitro CD36 overexpression rescued these detrimental metabolic and lipotoxic effects. Furthermore, in vivo cardiomyocyte-specific CD36 overexpression via AAV9-cTNT significantly attenuated erucic acid-induced cardiac fibrosis, mitochondrial damage, lipid peroxidation, and the glycolytic shift, firmly establishing CD36 as the central mediator. CONCLUSION: This study establishes erucic acid as a causal dietary metabolite that aggravates post-MI cardiac fibrosis. Its pathogenic mechanism involves the disruption of the cardioprotective CD36 lipid metabolism pathway, leading to mitochondrial dysfunction, lipotoxicity, and a detrimental bioenergetic shift. These findings highlight erucic acid and the CD36 axis as potential targets for risk stratification and dietary intervention following MI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Laboratory of Neuroscience and Tissue Engineering, Basic Medical College of Chongqing Medical University, Chongqing, China.
- Chongqing Medical University, Chongqing, China.
- Natural Drug Intervention in Aging Key Laboratory of Chongqing Education Commission of China Chongqing Three Gorges Medical College, Chongqing, China.
- Laboratory of Stem Cells and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Development and Utilization of Genuine Medicina…
- Department of Anatomy and Laboratory of Neuroscience and Tissue Engineering, Basic Medical College of Chongqing Medical University, Chongqing, China. Electronic address: 2025140060@stu.cqmu.edu.cn.
- Department of Anatomy and Laboratory of Neuroscience and Tissue Engineering, Basic Medical College of Chongqing Medical University, Chongqing, China; Western Institute of Digital-Intelligent Medicine, Chongqing 401329,…
Förderung
- National Natural Science Foundation of China
- Chongqing Municipal Education Commission
Zitieren
APA
Zhang, M., Wang, Q., Wang, X., Zhang, S., Chen, Y., Li, S., Zhang, L., Li, L., Li, G., Chen, D., Leng, J., & Ran, J. (2026). Erucic acid aggravates cardiac fibrosis after myocardial infarction by CD36-mediated metabolic reprogramming with impaired mitochondrial aerobic oxidation. Cellular Signalling, 146, 112636. https://doi.org/10.1016/j.cellsig.2026.112636
Vancouver
Zhang M, Wang Q, Wang X, Zhang S, Chen Y, Li S, et al. Erucic acid aggravates cardiac fibrosis after myocardial infarction by CD36-mediated metabolic reprogramming with impaired mitochondrial aerobic oxidation. Cellular Signalling. 2026;146:112636. doi:10.1016/j.cellsig.2026.112636
BibTeX
@article{Zhang2026,
author = {Zhang, Meng and Wang, Qiongfang and Wang, Xiaoyu and Zhang, Shengyao and Chen, Yutong and Li, Shihao and Zhang, Ling and Li, Letai and Li, Guoli and Chen, Dilong and Leng, Jiajie and Ran, Jianhua},
title = {Erucic acid aggravates cardiac fibrosis after myocardial infarction by CD36-mediated metabolic reprogramming with impaired mitochondrial aerobic oxidation},
journal = {Cellular Signalling},
year = {2026},
volume = {146},
pages = {112636},
doi = {10.1016/j.cellsig.2026.112636}
}
EUVIMED